Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Prophylaxis for PEG in MRSA Carriers
NCT00150852Phase 2Unknown
- Start
- Sep 2004
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of vancomycin in Wound infection (WI). Status: unknown.
02
Drugs
vancomycin
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on NCT00150852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150852.